Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$3.18
-4.5%
$3.78
$2.77
▼
$5.24
$1.98B1.1520.88 million shs16.58 million shs
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$29.53
-4.3%
$26.92
$10.94
▼
$34.00
$2.22B1.691.68 million shs1.28 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
0.00%-9.66%-23.56%+0.63%-31.61%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
0.00%-0.97%+15.89%+67.88%+64.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$3.18
-4.5%
$3.78
$2.77
▼
$5.24
$1.98B1.1520.88 million shs16.58 million shs
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$29.53
-4.3%
$26.92
$10.94
▼
$34.00
$2.22B1.691.68 million shs1.28 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
0.00%-9.66%-23.56%+0.63%-31.61%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
0.00%-0.97%+15.89%+67.88%+64.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2.20
Hold$8.18157.23% Upside
Schrodinger, Inc. stock logo
SDGR
Schrodinger
2.38
Hold$26.67-9.70% Downside

Current Analyst Ratings Breakdown

Latest SDGR and RXRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/5/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Boost Price TargetBuy$31.00 ➝ $36.00
11/3/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
DowngradeStrong-Buy ➝ Hold
10/20/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Boost Price TargetNeutral$19.00 ➝ $21.00
10/19/2026
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
Reiterated RatingBuy$8.00
10/16/2026
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
Set Price Target$5.90
10/16/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Boost Price TargetOverweight$20.00 ➝ $32.00
10/15/2026
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
Reiterated RatingSell (D-)
10/13/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Boost Price TargetBuy$20.00 ➝ $31.00
10/12/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Boost Price TargetOutperform$24.00 ➝ $30.00
10/5/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
UpgradeHold ➝ Strong-Buy
8/27/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 11/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$74.68M26.52N/AN/A$2.14 per share1.49
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$255.87M8.66N/AN/A$4.94 per share5.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$644.76M-$0.90N/AN/AN/A-697.15%-47.85%-36.26%N/A
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-$103.26M-$0.79N/AN/AN/A-22.02%-18.12%-9.07%N/A

Latest SDGR and RXRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-$0.6665-$0.50+$0.1665-$0.50$47.73 million$64.49 million
11/2/2026Q3 2026 & Study Update
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$0.2190-$0.22-$0.0010-$0.22$14.81 million$18.55 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/AN/AN/AN/AN/A
Schrodinger, Inc. stock logo
SDGR
Schrodinger
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/A
5.01
5.01
Schrodinger, Inc. stock logo
SDGR
Schrodinger
N/A
2.75
2.75

Institutional Ownership

CompanyInstitutional Ownership
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
89.06%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
79.05%

Insider Ownership

CompanyInsider Ownership
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
6.65%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
10.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
600622.76 million581.35 millionOptionable
Schrodinger, Inc. stock logo
SDGR
Schrodinger
85075.08 million67.50 millionOptionable

Recent News About These Companies

Schrödinger (SDGR) Stock Could Be Undervalued On Its 67% Run
Schrodinger (NASDAQ:SDGR) EVP Sells $1,051,200.00 in Stock
UBS Sticks to Its Hold Rating for Schrodinger (SDGR)
Schrodinger (NASDAQ:SDGR) Price Target Raised to $36.00
Schrödinger (SDGR) Q3 2026 Earnings Call Transcript
What Schrodinger (SDGR) Said on Its Q3 Earnings Call
Schrödinger Reports Third Quarter 2026 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Recursion Pharmaceuticals stock logo

Recursion Pharmaceuticals NASDAQ:RXRX

$3.18 -0.15 (-4.50%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$3.17 -0.01 (-0.31%)
As of 11/13/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Schrodinger stock logo

Schrodinger NASDAQ:SDGR

$29.53 -1.32 (-4.28%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$29.50 -0.03 (-0.10%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.